Indications and uses
- for treatment of acne - dries and clears acne pimples, blackheads, and whiteheads - helps prevent development of new acne pimples, blackheads, and whiteheads
- for treatment of acne - dries and clears acne pimples, blackheads, and whiteheads - helps prevent development of new acne pimples, blackheads, and whiteheads
- Cleanse the skin thoroughly before applying medication. - Apply a generous amount onto clean skin over the affected area, avoiding the eye area. - Leave on for 15 minutes. - Rinse thoroughly with warm water. - For best results, use twice a week.
Sulfur 5%
Acne Treatment
- for treatment of acne
- dries and clears acne pimples, blackheads, and whiteheads
- helps prevent development of new acne pimples, blackheads, and whiteheads
For external use only
using other topical acne medications at the same time or immediately following use of this product. This may increase dryness or irritation of the skin. If this occurs, only one medication should be used unless directed by a doctor.
do not get into eyes.
excessive skin irritation develops or increases.
If swallowed, get medical help or contact Poison Control Center right away.
- Cleanse the skin thoroughly before applying medication.
- Apply a generous amount onto clean skin over the affected area, avoiding the eye area.
- Leave on for 15 minutes.
- Rinse thoroughly with warm water.
- For best results, use twice a week.
Alcohol Denat, Benzyl Alcohol, Calcium Carbonate, Camphor, CetearylOlivate, Chamomile Oil, Dehydroacetic Acid, Glucose, Glycerin, Hawthron Stem Extract, Kaolin, Lavender Oil, Licorice Root Extract, Limonene, Linalool, Polysorbate 20, Sage Oil, Sorbitan Olivate, Manuka Oil, Thyme Oil, Water, Willow Bark Extract, Zinc Gluconate, Zinc Oxide
Please contact 732-553-1185 from 8:30 - 17:30 EST
SULFUR
LICORICE EXTRACT
ZINC GLUCONATE
WILLOW BARK EXTRACT
CALCIUM CARBONATE
KAOLIN
ESSENTIAL OILS
A treatment mask formulated to combat and help prevent acne. It will reduce visible blemishes and leave skin looking clear, calm and even toned.
Results: Absorbs sebum and gently exfloiates to decongest acne-causing blocked pores. Reduces the appearance of pore size and redness. Soothes and calms. Lightens the appearance of pigmented acne scars.
REN's ClearCalm 3 system combats the 3 key causes of acne and blemishes: excess sebum: build up of dead skin cells; blemish-causing bacteria.... without harshness.
Skin type
Acne prone skin. Problem skin prone to breakouts and blemishes
REN CLEAN BIO ACTIVE SKINCARE
NO
PETROCHEMICALS, SULFATES, PARABENS, SYNTHETIC FRAGRANCE, SYNTHETIC COLOURS, T.E.A., D.E.A., GLYCOLS, SILICONES, PEGS, ET AL
SKINCARE AS IT SHOULD BE
DERMATOLOGIST TESTED AND APPROVED REN IS AGAINST ANIMAL TESTING
Manufactured for:
REN Ltd, The Edison,
223-231
Old Marylebone Road,
London NW1 5QT
UK
Distributed by:
REN USA Inc,
250 Kennedy Drive,
Sayreville, New Jersey 08872
USA
Made in the UK
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| SULFUR | ACTIVE INGREDIENT | 70FD1KFU70 | 4 | |
| SULFUR | ACTIVE MOIETY | 70FD1KFU70 | 4 | |
| ALCOHOL | INACTIVE INGREDIENT | 3K9958V90M | 4 | |
| BENZYL ALCOHOL | INACTIVE INGREDIENT | LKG8494WBH | 4 | |
| CALCIUM CARBONATE | INACTIVE INGREDIENT | H0G9379FGK | 4 | |
| CAMPHOR (NATURAL) | INACTIVE INGREDIENT | N20HL7Q941 | 4 | |
| CHAMOMILE FLOWER OIL | INACTIVE INGREDIENT | 60F80Z61A9 | 4 | |
| DEHYDROACETIC ACID | INACTIVE INGREDIENT | 2KAG279R6R | 4 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | 4 | |
| KAOLIN | INACTIVE INGREDIENT | 24H4NWX5CO | 4 | |
| LAVENDER OIL | INACTIVE INGREDIENT | ZBP1YXW0H8 | 4 | |
| LINALOOL, DL- | INACTIVE INGREDIENT | D81QY6I88E | 4 | |
| MANUKA OIL | INACTIVE INGREDIENT | M6QU9ZUH2X | 4 | |
| POLYSORBATE 20 | INACTIVE INGREDIENT | 7T1F30V5YH | 4 | |
| SAGE OIL | INACTIVE INGREDIENT | U27K0H1H2O | 4 | |
| SORBITAN OLIVATE | INACTIVE INGREDIENT | MDL271E3GR | 4 | |
| THYME OIL | INACTIVE INGREDIENT | 2UK410MY6B | 4 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 4 | |
| WILLOW BARK | INACTIVE INGREDIENT | S883J9JDYX | 4 | |
| ZINC GLUCONATE | INACTIVE INGREDIENT | U6WSN5SQ1Z | 4 | |
| ZINC OXIDE | INACTIVE INGREDIENT | SOI2LOH54Z | 4 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 51417-3340 | 51417-3340-1, 51417-3340-2 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| ALCOHOL | 3K9958V90M | IACT |
| BENZYL ALCOHOL | LKG8494WBH | IACT |
| CALCIUM CARBONATE | H0G9379FGK | IACT |
| CAMPHOR (NATURAL) | N20HL7Q941 | IACT |
| CHAMOMILE FLOWER OIL | 60F80Z61A9 | IACT |
| DEHYDROACETIC ACID | 2KAG279R6R | IACT |
| GLYCERIN | PDC6A3C0OX | IACT |
| KAOLIN | 24H4NWX5CO | IACT |
| LAVENDER OIL | ZBP1YXW0H8 | IACT |
| LINALOOL, (+/-)- | D81QY6I88E | IACT |
| POLYSORBATE 20 | 7T1F30V5YH | IACT |
| SAGE OIL | U27K0H1H2O | IACT |
| SORBITAN OLIVATE | MDL271E3GR | IACT |
| MANUKA OIL | M6QU9ZUH2X | IACT |
| THYME OIL | 2UK410MY6B | IACT |
| WATER | 059QF0KO0R | IACT |
| WILLOW BARK | S883J9JDYX | IACT |
| ZINC GLUCONATE | U6WSN5SQ1Z | IACT |
| ZINC OXIDE | SOI2LOH54Z | IACT |
| SULFUR | 70FD1KFU70 | ACTIB |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| KAOLIN | KAOLIN | 24H4NWX5CO | SYSTEM / TOPICAL | 420 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION / INTRAMUSCULAR | 1491 mg | ||
| KAOLIN | KAOLIN | 24H4NWX5CO | POWDER / TOPICAL | 10056 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET, FILM COATED / ORAL | 1.55 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / OPHTHALMIC | 6 %w/v | ||
| POLYSORBATE 20 | POLYSORBATE 20 | 7T1F30V5YH | INJECTION, SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | 60 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION/ DROPS / OPHTHALMIC | 12 mg | ||
| BENZYL ALCOHOL | BENZYL ALCOHOL | LKG8494WBH | SUSPENSION / TOPICAL | 1 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | OINTMENT / TOPICAL | NA | ||
| POLYSORBATE 20 | POLYSORBATE 20 | 7T1F30V5YH | INJECTION, SOLUTION / SUBCUTANEOUS | NA | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | GUM, CHEWING / BUCCAL | 230 mg | ||
| BENZYL ALCOHOL | BENZYL ALCOHOL | LKG8494WBH | TABLET / ORAL | 1.06 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SPRAY / NASAL | 22.3 mg/1ml | ||
| POLYSORBATE 20 | POLYSORBATE 20 | 7T1F30V5YH | INJECTION / INTRAMUSCULAR | 1.62 %w/v | ||
| POLYSORBATE 20 | POLYSORBATE 20 | 7T1F30V5YH | TABLET, FILM COATED / ORAL | 0.35 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / ORAL | 32400 mg | ||
| BENZYL ALCOHOL | BENZYL ALCOHOL | LKG8494WBH | INJECTION / INTRA-ARTERIAL | 0.9 %w/v | ||
| ZINC OXIDE | ZINC OXIDE | SOI2LOH54Z | LOTION / TOPICAL | 16 %w/w | ||
| CALCIUM CARBONATE | CALCIUM CARBONATE | H0G9379FGK | TABLET, DELAYED RELEASE / ORAL | 8.4 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL / TRANSDERMAL | 7360 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SYRUP / ORAL | 21000 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SYSTEM / IONTOPHORESIS | 168.1 mg | ||
| ZINC OXIDE | ZINC OXIDE | SOI2LOH54Z | INJECTION, SUSPENSION / SUBCUTANEOUS | NA | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | DROPS / NASAL | 10 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / INTRAVENOUS | 400 mg | ||
| KAOLIN | KAOLIN | 24H4NWX5CO | TABLET / ORAL | 150 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LOTION / TOPICAL | 25 %w/w | ||
| BENZYL ALCOHOL | BENZYL ALCOHOL | LKG8494WBH | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | 144 mg | ||
| BENZYL ALCOHOL | BENZYL ALCOHOL | LKG8494WBH | CAPSULE / ORAL | 450 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CAPSULE, EXTENDED RELEASE / ORAL | 265 mg | ||
| CALCIUM CARBONATE | CALCIUM CARBONATE | H0G9379FGK | SOLUTION / INTRAVENOUS | 4.02 %w/v | ||
| KAOLIN | KAOLIN | 24H4NWX5CO | CAPSULE / ORAL | NA | ||
| LAVENDER OIL | LAVENDER OIL | ZBP1YXW0H8 | GEL / TOPICAL | 0.1 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, FOAM / TOPICAL | 4504 mg | ||
| KAOLIN | KAOLIN | 24H4NWX5CO | POWDER, FOR SUSPENSION / ORAL | NA | ||
| CALCIUM CARBONATE | CALCIUM CARBONATE | H0G9379FGK | POWDER, DENTIFRICE / DENTAL | 0.5 mg/mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / INTRADERMAL | 1.6 %w/v | ||
| BENZYL ALCOHOL | BENZYL ALCOHOL | LKG8494WBH | INJECTION / SOFT TISSUE | 23 mg | ||
| BENZYL ALCOHOL | BENZYL ALCOHOL | LKG8494WBH | OINTMENT / TOPICAL | 2.2 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SYRUP / ORAL | 16734 mg | ||
| BENZYL ALCOHOL | BENZYL ALCOHOL | LKG8494WBH | CREAM / TOPICAL | 160 mg | ||
| BENZYL ALCOHOL | BENZYL ALCOHOL | LKG8494WBH | GEL / VAGINAL | 100 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION, CONCENTRATE / ORAL | 200 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CONCENTRATE / ORAL | 198 mg | ||
| POLYSORBATE 20 | POLYSORBATE 20 | 7T1F30V5YH | CAPSULE / ORAL | 563 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CONCENTRATE / ORAL | 1800 mg | ||
| BENZYL ALCOHOL | BENZYL ALCOHOL | LKG8494WBH | SUSPENSION / ORAL | 100 mg | ||
| KAOLIN | KAOLIN | 24H4NWX5CO | CAPSULE, COATED PELLETS / ORAL | 234 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / RESPIRATORY (INHALATION) | 5 %w/w | ||
| CALCIUM CARBONATE | CALCIUM CARBONATE | H0G9379FGK | TABLET, CHEWABLE / ORAL | 1650 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL / RECTAL | 898 mg | ||
| BENZYL ALCOHOL | BENZYL ALCOHOL | LKG8494WBH | INJECTION, EMULSION / INTRAVENOUS | 45 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET / ORAL | 42 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | PASTE, DENTIFRICE / DENTAL | 18 %w/w | ||
| CALCIUM CARBONATE | CALCIUM CARBONATE | H0G9379FGK | CAPSULE, DELAYED RELEASE / ORAL | 20 mg | ||
| KAOLIN | KAOLIN | 24H4NWX5CO | TABLET, COATED / ORAL | 52.44 mg | ||
| CALCIUM CARBONATE | CALCIUM CARBONATE | H0G9379FGK | TABLET, EXTENDED RELEASE / ORAL | 229.7 mg | ||
| BENZYL ALCOHOL | BENZYL ALCOHOL | LKG8494WBH | INJECTION, EMULSION / SUBCUTANEOUS | 225 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION/ DROPS / AURICULAR (OTIC) | 25 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CREAM / VAGINAL | 60 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| f0f198cf-9114-3311-e053-2995a90a438a | 109775dd-cdb4-4e48-9925-9c3b975b7433 | 2022-12-29 | Warnings | 109775dd-cdb4-4e48-9925-9c3b975b7433 |
Adverse event summaries are temporarily unavailable. Other product information remains available.